These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 32571092)

  • 1. Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases: A Nationwide Study.
    Zareini B; Blanche P; D'Souza M; Elmegaard Malik M; Nørgaard CH; Selmer C; Gislason G; Kristensen SL; Køber L; Torp-Pedersen C; Schou M; Lamberts M
    Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006260. PubMed ID: 32571092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims database.
    Blin P; Joubert M; Jourdain P; Zaoui P; Guiard E; Sakr D; Dureau-Pournin C; Bernard MA; Lassalle R; Thomas-Delecourt F; Bineau S; Moore N; Droz-Perroteau C
    Cardiovasc Diabetol; 2024 Jan; 23(1):22. PubMed ID: 38195491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics, precipitating factors, management and outcome of patients with prior stroke hospitalised with heart failure: an observational report from the Middle East.
    Khafaji HA; Sulaiman K; Singh R; AlHabib KF; Asaad N; Alsheikh-Ali A; Al-Jarallah M; Bulbanat B; AlMahmeed W; Ridha M; Bazargani N; Amin H; Al-Motarreb A; AlFaleh H; Elasfar A; Panduranga P; Al Suwaidi J
    BMJ Open; 2015 Apr; 5(4):e007148. PubMed ID: 25908674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study.
    Thein D; Christiansen MN; Mogensen UM; Bundgaard JS; Rørth R; Madelaire C; Fosbøl EL; Schou M; Torp-Pedersen C; Gislason G; Køber L; Kristensen SL
    Cardiovasc Diabetol; 2020 Jul; 19(1):107. PubMed ID: 32631337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors, outcomes and healthcare utilisation in individuals with multimorbidity including heart failure, chronic kidney disease and type 2 diabetes mellitus: a national electronic health record study.
    Pasea L; Dashtban A; Mizani M; Bhuva A; Morris T; Mamza JB; Banerjee A
    Open Heart; 2023 Sep; 10(2):. PubMed ID: 37758654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of heart failure in type 2 diabetes complicated by incident ischaemic heart disease and end-stage renal disease.
    Malik ME; Madelaire C; D'Souza M; Blanche P; Kristensen SL; Kistorp C; Gustafsson F; Køber L; Rørth R; McMurray J; Sattar N; Gislason G; Torp-Pedersen C; Schou M
    Eur J Heart Fail; 2020 May; 22(5):813-820. PubMed ID: 32246806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationwide prediction of type 2 diabetes comorbidities.
    Dworzynski P; Aasbrenn M; Rostgaard K; Melbye M; Gerds TA; Hjalgrim H; Pers TH
    Sci Rep; 2020 Feb; 10(1):1776. PubMed ID: 32019971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study.
    Zhao Q; Wang L; Kurlansky PA; Schein J; Baser O; Berger JS
    BMC Cardiovasc Disord; 2019 Jan; 19(1):19. PubMed ID: 30646855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of cardiovascular outcomes in heart failure patients with new-onset, prevalent, and without type 2 diabetes.
    Zareini B; Blanche P; Holt A; Malik ME; Selmer C; Gislason G; Kristensen SL; Køber L; Torp-Pedersen C; Schou M; Lamberts M
    Clin Res Cardiol; 2022 Apr; 111(4):460-468. PubMed ID: 35072773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure and the prognostic impact and incidence of new-onset of diabetes mellitus: a nationwide cohort study.
    Zareini B; Rørth R; Holt A; Mogensen UM; Selmer C; Gislason G; Schou M; Køber L; Torp-Pedersen C; Lamberts M; Kristensen SL
    Cardiovasc Diabetol; 2019 Jun; 18(1):79. PubMed ID: 31189473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Potassium Levels in Patients With Congestive Heart Failure: Occurrence, Risk Factors, and Clinical Outcomes: A Danish Population-Based Cohort Study.
    Thomsen RW; Nicolaisen SK; Hasvold P; Garcia-Sanchez R; Pedersen L; Adelborg K; Egfjord M; Egstrup K; Sørensen HT
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29789332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients.
    Ducluzeau PH; Fauchier G; Herbert J; Semaan C; Halimi JM; Angoulvant D; Fauchier L
    Diabetes Metab; 2023 May; 49(3):101429. PubMed ID: 36736892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort-the DIABET-IC study.
    Gonzalez-Manzanares R; Anguita-Gámez M; Muñiz J; Barrios V; Gimeno-Orna JA; Pérez A; Rodríguez-Padial L; Anguita M;
    Cardiovasc Diabetol; 2024 Jul; 23(1):253. PubMed ID: 39014420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of type 2 diabetes on life expectancy and role of kidney disease among inpatients with heart failure in Switzerland: an ambispective cohort study.
    Salvador D; Bano A; Wehrli F; Gonzalez-Jaramillo V; Laimer M; Hunziker L; Muka T
    Cardiovasc Diabetol; 2023 Jul; 22(1):174. PubMed ID: 37438747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.
    Sigvant B; Hasvold P; Kragsterman B; Falkenberg M; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2017 Aug; 66(2):507-514.e1. PubMed ID: 28433332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preheart failure comorbidities and impact on prognosis in heart failure patients: a nationwide study.
    Christiansen MN; Køber L; Torp-Pedersen C; Gislason GH; Schou M; Smith JG; Vasan RS; Andersson C
    J Intern Med; 2020 Jun; 287(6):698-710. PubMed ID: 32103571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease.
    Patel PA; Liang L; Khazanie P; Hammill BG; Fonarow GC; Yancy CW; Bhatt DL; Curtis LH; Hernandez AF
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction.
    Jensen J; Schou M; Kistorp C; Faber J; Hansen TW; Jensen MT; Andersen HU; Rossing P; Vilsbøll T; Jørgensen PG
    Cardiovasc Diabetol; 2020 Oct; 19(1):180. PubMed ID: 33066783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors, treatment and prognosis in men and women with heart failure with and without diabetes.
    Johansson I; Dahlström U; Edner M; Näsman P; Rydén L; Norhammar A
    Heart; 2015 Jul; 101(14):1139-48. PubMed ID: 26034118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.